Investor profile
Meltwind has backed 13 European tech companies across 15 funding rounds between 2021 and 2026, joining rounds totalling €142M. Most active in Healthtech and Software. Data as of 6 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Inotec Amd | UK | 1 | €31M |
| Qureight | UK | 3 | €27M |
| ViaNautis | UK | 1 | €23M |
| Enhanced Genomics | UK | 1 | €16M |
| Closed Loop Medicine | UK |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Inotec Amd | Series C | €31M | 2024-12 |
| ViaNautis | Series A | €23M | 2023-11 |
| Enhanced Genomics | Series A | €16M | 2025-09 |
| Closed Loop Medicine |
| 1 |
| €15M |
| NanoSyrinx | UK | 1 | €12M |
| Tagomics | UK | 1 | €6.2M |
| Axol Bioscience | UK | 1 | €3.8M |
| Psyomics | UK | 1 | €2.8M |
| Sanome | UK | 1 | €2.3M |
| 52 North Health | UK | 1 | €1.2M |
| Five Alarm Bios | UK | 1 | €568k |
| Scarlet Therapeutics | UK | 1 | €0 |
| Series A |
| €15M |
| 2021-11 |
| NanoSyrinx | Other | €12M | 2024-09 |
| Qureight | Series A | €8.0M | 2024-04 |
| Tagomics | Other | €6.2M | 2024-02 |
| Axol Bioscience | Other | €3.8M | 2022-04 |
| Psyomics | Other | €2.8M | 2022-06 |
| Sanome | Other | €2.3M | 2021-09 |
